The 20th Regulatory Affairs and Pharmacovigilance conference of Medicines for Europe keeps on providing useful insights of the path ahead.
Digitalisation has been mentioned as one of the main pillars within the Pharmaceutical Strategy for Europe, being considered a key tool to easy the regulatory burden, facilitate the communication between all the stakeholders, and address particular needs of the regulatory landscape. The two most highlighted examples are the use of electronic product information and the simplification of regulatory procedures through digital platforms.
Our Asphalion experts Lidia Cánovas, General Manager, Regulatory Affairs and Eduardo Garrido, Medical Device Officer are attending the congress.
Next congress sessions are scheduled on the 2nd and 4th of February.
At Asphalion we will stay tuned to keep you updated on all forthcoming changes!
If you have any questions do not hesitate to contact us at: info@asphalion.com
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
